Pasithea Therapeutics Corp. Common Stock
Symbol: KTTA (NASDAQ)
Company Description:
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
- Today's Open: $0.71
- Today's High: $0.751
- Today's Low: $0.657
- Today's Volume: 68.52K
- Yesterday Close: $0.7099
- Yesterday High: $0.735
- Yesterday Low: $0.7
- Yesterday Volume: 32.21K
- Last Min Volume: 100
- Last Min High: $0.717
- Last Min Low: $0.717
- Last Min VWAP: $0.717
- Name: Pasithea Therapeutics Corp. Common Stock
- Website: https://www.pasithea.com
- Listed Date: 2021-09-15
- Location: MIAMI BEACH, FL
- Market Status: Active
- CIK Number: 0001841330
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $5.28M
- Round Lot: 100
- Outstanding Shares: 7.44M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-09-16 | 8-K | View |
2025-09-09 | S-8 | View |
2025-09-03 | 8-K | View |
2025-08-14 | 10-Q | View |
2025-08-14 | SCHEDULE 13G/A | View |
2025-07-24 | ARS | View |
2025-07-24 | DEF 14A | View |
2025-07-14 | PRE 14A | View |
2025-07-11 | 8-K | View |
2025-06-27 | 8-K | View |
2025-06-20 | 8-K | View |
2025-06-20 | 424B5 | View |
2025-05-15 | 10-Q | View |
2025-05-15 | SCHEDULE 13G/A | View |
2025-05-14 | 144 | View |
2025-05-14 | 4 | View |
2025-05-12 | SCHEDULE 13G | View |
2025-05-12 | SCHEDULE 13G | View |
2025-05-09 | SCHEDULE 13G/A | View |
2025-05-09 | SCHEDULE 13G | View |